Gill Ross

821 total citations
13 papers, 577 citations indexed

About

Gill Ross is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Gill Ross has authored 13 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Cancer Research. Recurrent topics in Gill Ross's work include Breast Cancer Treatment Studies (4 papers), Brain Metastases and Treatment (3 papers) and HER2/EGFR in Cancer Research (3 papers). Gill Ross is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Brain Metastases and Treatment (3 papers) and HER2/EGFR in Cancer Research (3 papers). Gill Ross collaborates with scholars based in United Kingdom, United States and Australia. Gill Ross's co-authors include Ellen M. Donovan, Jane Hanson, Diana Tait, John Yarnold, Lone Gothard, Philip Evans, Stephanie Reise, Clare Peckitt, Richard Symonds‐Tayler and Andrew Tutt and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Gill Ross

13 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gill Ross United Kingdom 7 324 236 214 178 143 13 577
S. Heymann France 12 236 0.7× 140 0.6× 81 0.4× 178 1.0× 109 0.8× 33 450
Adrian Murray Brunt United Kingdom 14 344 1.1× 131 0.6× 180 0.8× 372 2.1× 109 0.8× 50 752
Roger Owen United Kingdom 11 578 1.8× 248 1.1× 372 1.7× 262 1.5× 191 1.3× 11 897
Christer Svedman United States 13 332 1.0× 101 0.4× 104 0.5× 228 1.3× 416 2.9× 28 746
Charles E. Leonard United States 11 392 1.2× 200 0.8× 99 0.5× 224 1.3× 212 1.5× 34 621
Maria Fenton-Kerimian United States 11 280 0.9× 210 0.9× 190 0.9× 471 2.6× 200 1.4× 26 855
Iwa Kong Canada 12 472 1.5× 163 0.7× 100 0.5× 196 1.1× 71 0.5× 29 597
Carla De Luca Cardillo Italy 6 302 0.9× 167 0.7× 99 0.5× 169 0.9× 99 0.7× 21 442
Anita Ashton United Kingdom 8 804 2.5× 435 1.8× 348 1.6× 296 1.7× 159 1.1× 8 1.0k
Linda Sciuto United States 9 445 1.4× 90 0.4× 139 0.6× 266 1.5× 130 0.9× 16 725

Countries citing papers authored by Gill Ross

Since Specialization
Citations

This map shows the geographic impact of Gill Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gill Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gill Ross more than expected).

Fields of papers citing papers by Gill Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gill Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gill Ross. The network helps show where Gill Ross may publish in the future.

Co-authorship network of co-authors of Gill Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Gill Ross. A scholar is included among the top collaborators of Gill Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gill Ross. Gill Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kirby, Anna M., Imogen Locke, S. Settatree, et al.. (2025). Oncotype DX Breast DCIS Score® Test: Impact on Radiotherapy Recommendations and Patient Decisional Anxiety. Clinical Oncology. 42. 103839–103839. 1 indexed citations
2.
Ross, Gill, et al.. (2024). Patient Perspectives on the Value of Stereotactic Body Radiotherapy in the Management of Breast Cancer: The PERSPECTIVE Study. Clinical Oncology. 38. 103738–103738. 1 indexed citations
3.
4.
5.
Aitken, K., Alison Tree, Karen Thomas, et al.. (2015). Initial UK Experience of Stereotactic Body Radiotherapy for Extracranial Oligometastases: Can We Change the Therapeutic Paradigm?. Clinical Oncology. 27(7). 411–419. 30 indexed citations
6.
Schick, Ulrike, et al.. (2015). Breast cancer brain metastases – A 12 year review of treatment outcomes. The Breast. 24(4). 426–433. 22 indexed citations
7.
Robertson, Lindsay B., Helen Hanson, S. Seal, et al.. (2012). BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. British Journal of Cancer. 106(6). 1234–1238. 79 indexed citations
8.
Baselga, José, Javier Cortés, S-A Im, et al.. (2012). Abstract S5-1: Biomarker analyses in CLEOPATRA: A phase III, placebo-controlled study of pertuzumab in HER2-positive, first-line metastatic breast cancer (MBC). Cancer Research. 72(24_Supplement). S5–1. 46 indexed citations
9.
10.
Cortés, Javier, José Baselga, P. Fumoleau, et al.. (2010). Pertuzumab and trastuzumab: Exploratory biomarker correlations with clinical benefit in patients with metastatic HER2-positive breast cancer.. Journal of Clinical Oncology. 28(15_suppl). 1066–1066. 2 indexed citations
11.
Donovan, Ellen M., Philip Evans, Lone Gothard, et al.. (2007). Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiotherapy and Oncology. 82(3). 254–264. 352 indexed citations
12.
Ross, Gill, et al.. (2006). Closed Blunt-trocar 5???mm-port for Primary Cannulation in Laparoscopic Surgery: A Safe Technique. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 16(3). 156–160. 5 indexed citations
13.
Tutt, Andrew, Frances Connor, David Bertwistle, et al.. (2003). Cell cycle and genetic background dependence of the effect of loss of BRCA2 on ionizing radiation sensitivity. Oncogene. 22(19). 2926–2931. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Heymann Breakdown of academic impact, for papers by Adrian Murray Brunt Breakdown of academic impact, for papers by Roger Owen Breakdown of academic impact, for papers by Christer Svedman Breakdown of academic impact, for papers by Charles E. Leonard Breakdown of academic impact, for papers by Maria Fenton-Kerimian Breakdown of academic impact, for papers by Iwa Kong Breakdown of academic impact, for papers by Carla De Luca Cardillo Breakdown of academic impact, for papers by Anita Ashton Breakdown of academic impact, for papers by Linda Sciuto
Rankless by CCL
2026